Company intelligence / Profile preview

Vitaflo USA

United States

Ownership: Private
Development stage: Other

Overview

Vitaflo develops and commercializes specialized medical foods and clinical nutrition products for inherited metabolic diseases, kidney disease, and ketogenic diet indications, supported by clinical trials and used globally as part of dietary management, not as drugs.[1][2][3][4][6]

Therapeutic areas: NephrologyGastroenterologyMetabolic Disorders
Modalities: Non-pharmacological therapyMedical foodNutritional product
Industry: Food & Nutrition

Partnerships

Nestlé Health Science (brand owned and integrated within its medical nutrition portfolio)[3][6]

Beyond the preview

Go deeper on Vitaflo USA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitaflo USA.

Explore the full profile